Firefly Neuroscience (NASDAQ:AIFF) & Augmedix (OTCMKTS:AUGX) Head to Head Review

Firefly Neuroscience (NASDAQ:AIFF) and Augmedix (OTCMKTS:AUGX) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, dividends, institutional ownership, profitability, analyst recommendations, earnings and risk.

Insider and Institutional Ownership

5.0% of Firefly Neuroscience shares are owned by institutional investors. Comparatively, 87.1% of Augmedix shares are owned by institutional investors. 6.9% of Firefly Neuroscience shares are owned by insiders. Comparatively, 11.0% of Augmedix shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Valuation & Earnings

This table compares Firefly Neuroscience and Augmedix”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Firefly Neuroscience	$1.80 million	9.86	-$19.88 million	($0.59)	-1.92
Augmedix	$51.58 million	2.23	-$24.45 million	($0.43)	-5.47

Firefly Neuroscience has higher earnings, but lower revenue than Augmedix. Augmedix is trading at a lower price-to-earnings ratio than Firefly Neuroscience, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a summary of current recommendations and price targets for Firefly Neuroscience and Augmedix, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Firefly Neuroscience	1	0	0	0	1.00
Augmedix	0	0	0	0	0.00

Volatility & Risk

Firefly Neuroscience has a beta of 0.57, indicating that its stock price is 43% less volatile than the S&P 500. Comparatively, Augmedix has a beta of -0.22, indicating that its stock price is 122% less volatile than the S&P 500.

Profitability

This table compares Firefly Neuroscience and Augmedix’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Firefly Neuroscience	-506.23%	-90.17%	-72.05%
Augmedix	-57.70%	-980.09%	-57.85%

About Firefly Neuroscience

Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.

About Augmedix

Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live that provides synchronous medical note documentation and point of care support; Augmedix Go Assist that offers asynchronous medical documentation based upon previously recorded visits; Augmedix Prep that provides patient demographics, past medical history, medication changes and other points from the patient's health record; and Augmedix Go, an autonomous, ambient AI mobile software application that offers fully automated medical documentation based upon recorded visits. The company enables clinicians to access its applications through mobile devices, such as smartphones. It serves health systems and specialty groups. The company was founded in 2013 and is headquartered in San Francisco, California.